Γ
Content Highlights || Full Agenda
Breakout Session

•

4:30 PM

-

5:15 PM

Planetary Health

The New Main Course: Cultured Meat + Precision Fermentation

Plant-based food sales may be slowing, but that doesn’t mean innovation on the plate is stalling. Instead, momentum is shifting toward breakthrough technologies and smarter ingredient combinations. Cultured meat and precision fermentation are driving the next wave of sustainable ingredients, from proteins to cultured fats that bring authentic flavor and texture. This session highlights advances in cell culture, fermentation platforms, and scale-up strategies, along with the partnerships moving products from R&D to dining tables. Hear how food innovators are combining biology and culinary creativity to build a resilient, delicious, and sustainable future for global diets.

Get a Ticket

Join

Featuring

Max Jamilly

Hoxton Farms

CEO & Co-founder

Cultivated-fat pioneer making alt-meat taste real.

Laura Kliman

Impossible Foods

Senior R&D Director

Making plant-based meat possible

Isabelle Decitre

ID Capital

Founder

Future Food Asia founder. Synbio food-systems investor.

Jason Ryder

Oobli

Founder & CTO

Turns exotic sweet proteins into craveable sweetness without sugar.

Megan Thomas

Ladder 17

Founder & CEO

Launched the first CRISPR food in the US, award-winning storytelling podcast host.

Breakout Session

•

4:30 PM

-

5:15 PM

Planetary Health

The New Main Course: Cultured Meat + Precision Fermentation

Plant-based food sales may be slowing, but that doesn’t mean innovation on the plate is stalling. Instead, momentum is shifting toward breakthrough technologies and smarter ingredient combinations. Cultured meat and precision fermentation are driving the next wave of sustainable ingredients, from proteins to cultured fats that bring authentic flavor and texture. This session highlights advances in cell culture, fermentation platforms, and scale-up strategies, along with the partnerships moving products from R&D to dining tables. Hear how food innovators are combining biology and culinary creativity to build a resilient, delicious, and sustainable future for global diets.

Get a Ticket

Join

Featuring

Max Jamilly

Hoxton Farms

CEO & Co-founder

Cultivated-fat pioneer making alt-meat taste real.

Laura Kliman

Impossible Foods

Senior R&D Director

Making plant-based meat possible

Isabelle Decitre

ID Capital

Founder

Future Food Asia founder. Synbio food-systems investor.

Jason Ryder

Oobli

Founder & CTO

Turns exotic sweet proteins into craveable sweetness without sugar.

Megan Thomas

Ladder 17

Founder & CEO

Launched the first CRISPR food in the US, award-winning storytelling podcast host.

Back to Full Schedule

Back to Full Schedule

SynBioBeta is where the people building with biology meet the people funding, buying, and partnering with them. If you're raising capital, scouting the next wave of AIxBIO companies, or looking for your next technology partner - the people you need are here for three days.

The startups on stage this year are building programmable RNA medicines, virtual cell models, AI-designed enzymes, and proteins that replace sugar - alongside GSK, Sanofi, Novo Nordisk, Eli Lilly, J&J, Mars, Apple, Google, NVIDIA, Unilever, and P&G.

Watching where the partnerships form and which technologies the biggest players are actually evaluating is something you can't get from a report or a webinar. And our 1:1 Partnering App lets you book meetings before you arrive.

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”
“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

Eric Schmidt

Former CEO

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

Celestine Schnugg

Founder

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."
"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

Surge Biswas

Founder

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."
"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

Jacob Glanville

Founder & CEO

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."
"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

Bill Tai

Co-founder

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."
"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

Luis Cascao-Pereira

Head of Digital Biology

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."
"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Ola Wlodek

CEO

Who’s Coming to SynBioBeta?

Funders writing checks and looking for their next company.

Jenny Rooke

Genoa Ventures

Managing Director

Jenny Rooke

Genoa Ventures

Managing Director

Jessica Owens

Initiate Ventures

Managing Partner

Jessica Owens

Initiate Ventures

Managing Partner

Alicia Jackson

ARPA-H

Director

Alicia Jackson

ARPA-H

Director

Elliot Hershberg

Amplify Partners

Partner, Author

Elliot Hershberg

Amplify Partners

Partner, Author

Fan Yang

Capital O

Partner

Fan Yang

Capital O

Partner

Liliana Nordbakk

NEVA SGR

Partner

Liliana Nordbakk

NEVA SGR

Partner

Omri Amirav-Drory

NFX

General Partner

Omri Amirav-Drory

NFX

General Partner

Michael Koeris

DARPA

Director, BTO

Michael Koeris

DARPA

Director, BTO

David Welch

Synthesis Capital

CSO & Co-founder

David Welch

Synthesis Capital

CSO & Co-founder

Shelby Newsad

Compound

Partner

Shelby Newsad

Compound

Partner

Lauren Greenlee

XPRIZE

EVP

Lauren Greenlee

XPRIZE

EVP

Po Bronson

SOSV

General Partner

Po Bronson

SOSV

General Partner

Karl Handelsman

Codon Capital

Managing Partner

Karl Handelsman

Codon Capital

Managing Partner

Alice Pettitt

ARIA

Frontier Specialist

Alice Pettitt

ARIA

Frontier Specialist

Jessica Green

ARPA-H

Program Manager

Jessica Green

ARPA-H

Program Manager

Kit McDonnell

Superorganism VC

Head of Ecosystem

Kit McDonnell

Superorganism VC

Head of Ecosystem

The Startups they'll be meeting with.

Marc Tessier-Lavigne

Xaira

Chairman & CEO

Marc Tessier-Lavigne

Xaira

Chairman & CEO

Ron Alfa

NOETIK Inc.

Co-Founder & CEO

Ron Alfa

NOETIK Inc.

Co-Founder & CEO

Christina Smolke

Antheia

CEO & Co-Founder

Christina Smolke

Antheia

CEO & Co-Founder

Simon Kohl

Latent Labs

Founder & CEO

Simon Kohl

Latent Labs

Founder & CEO

Jacob Becraft

Strand

CEO & Co-founder

Jacob Becraft

Strand

CEO & Co-founder

Jen Asher

1910

Founder & CEO

Jen Asher

1910

Founder & CEO

Ola Wlodek

Constructive Bio

CEO

Ola Wlodek

Constructive Bio

CEO

Daniel de la Torre

Constructive Bio

VP of R&D

Daniel de la Torre

Constructive Bio

VP of R&D

Elise de Reus

Cradle

Co-founder

Elise de Reus

Cradle

Co-founder

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Jacob Glanville

Centivax

CEO

Jacob Glanville

Centivax

CEO

Micha Breakstone

Cellular Intelligence

Co-founder & CEO

Micha Breakstone

Cellular Intelligence

Co-founder & CEO

Eric Kelsic

Dyno Therapeutics

CEO

Eric Kelsic

Dyno Therapeutics

CEO

Relly Brandman

A-Life / Google X

Moonshot Lead

Relly Brandman

A-Life / Google X

Moonshot Lead

Emily Leproust

Twist Bioscience

CEO

Emily Leproust

Twist Bioscience

CEO

Gabriele Corso

Boltz

CEO

Gabriele Corso

Boltz

CEO

Matt Angle

Paradromics

Founder & CEO

Matt Angle

Paradromics

Founder & CEO

Eric Nguyen

Radical Numerics

Co-founder & CEO

Eric Nguyen

Radical Numerics

Co-founder & CEO

Peyton Greenside

BigHat Biosciences

CEO & Co-Founder

Peyton Greenside

BigHat Biosciences

CEO & Co-Founder

And the BD and R&D Leads
That Will Be Your Customers and Partners:

Mikah Coffindaffer

Procter & Gamble

R&D Director

Mikah Coffindaffer

Procter & Gamble

R&D Director

Neil Parry

Unilever

R&D Dir. Biotech

Neil Parry

Unilever

R&D Dir. Biotech

Gregory Hocking

Mars Snacking

VP Global R&D New Innov. Territories

Gregory Hocking

Mars Snacking

VP Global R&D New Innov. Territories

Ling Li

ADM

Dir. Market Dev., Prec. Ferm.

Ling Li

ADM

Dir. Market Dev., Prec. Ferm.

Kim Branson

GlaxoSmithKline

SVP, Global Head

Kim Branson

GlaxoSmithKline

SVP, Global Head

Ashoka Madduri

Sanofi

Head, Scientific Strategy

Ashoka Madduri

Sanofi

Head, Scientific Strategy

Peter Clark

Novo Nordisk

VP, CDD

Peter Clark

Novo Nordisk

VP, CDD

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Amy Jenkins

AstraZeneca

Sr Dir, Strat & Ops

Susan Klaeger

Genentech

Principal Scientist

Susan Klaeger

Genentech

Principal Scientist

Vanessa Braunstein

Eli Lilly

Sr. Director, Tunelab

Vanessa Braunstein

Eli Lilly

Sr. Director, Tunelab

Kristina Kitko

Eli Lilly

Director of Venture

Kristina Kitko

Eli Lilly

Director of Venture

Ekaterine Kortkhonjia

J&J

Sr. Dir, Transactions

Ekaterine Kortkhonjia

J&J

Sr. Dir, Transactions

Josh Armstrong

Corteva

Discovery & Bioprocess Leader

Josh Armstrong

Corteva

Discovery & Bioprocess Leader

Lyle Ralston

Bayer Crop Science

CE Platform Lead

Lyle Ralston

Bayer Crop Science

CE Platform Lead

Leah Briscoe

Bayer Crop Science

Data Scientist

Leah Briscoe

Bayer Crop Science

Data Scientist

Tommi White

Bayer Crop Science

Structure & Mech. Team Lead

Tommi White

Bayer Crop Science

Structure & Mech. Team Lead

Paramita Deria

Bayer Crop Science

Discovery Chem. & Chem. Biology

Paramita Deria

Bayer Crop Science

Discovery Chem. & Chem. Biology

Alberto Iandolino

Bayer Crop Science

Ext. Innov. & Partnership - Biologics

Alberto Iandolino

Bayer Crop Science

Ext. Innov. & Partnership - Biologics

Colby Adolph

Evonik

Sales Director

Colby Adolph

Evonik

Sales Director

Laura Kliman

Impossible Foods

Senior R&D Director

Laura Kliman

Impossible Foods

Senior R&D Director

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Paul Bielewicz

W. L. Gore & Associates

Dir. of Innov. & Venture Dev.

Riccardo LoCascio

Novonesis

Partnering - Precision Proteins

Riccardo LoCascio

Novonesis

Partnering - Precision Proteins

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Cynthia Collins

Ginkgo Bioworks

GM, Ginkgo Reagents

Get a Ticket

Get a Ticket